Wang, Bei http://orcid.org/0000-0002-9530-0385
Deng, Rong http://orcid.org/0000-0003-2005-7517
Hennig, Stefanie http://orcid.org/0000-0001-5972-3711
Badovinac Crnjevic, Tanja http://orcid.org/0000-0002-0922-3409
Kaewphluk, Monika http://orcid.org/0000-0002-0637-7509
Kågedal, Matts http://orcid.org/0000-0002-1261-0354
Quartino, Angelica L. http://orcid.org/0000-0003-0184-4670
Girish, Sandhya http://orcid.org/0000-0002-9336-1600
Li, Chunze http://orcid.org/0000-0002-8906-6553
Kirschbrown, Whitney P. http://orcid.org/0000-0003-0580-5425
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Article History
Received: 1 December 2020
Accepted: 15 May 2021
First Online: 9 June 2021
Change Date: 24 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00280-021-04342-x
Declarations
:
: Bei Wang, Matts Kågedal, Chunze Li, and Whitney P. Kirschbrown are employees of Genentech, Inc. and own stock in Roche Holding Ltd. Angelica L. Quartino was an employee of Genentech, Inc. at the time of the study. Sandhya Girish was an employee of Genentech, Inc. and owned stock in Roche Holding Ltd at the time of the study. Rong Deng is an independent consultant for Genentech, Inc. Tanja Badovinac Crnjevic and Monika Kaewphluk are employees of and hold stocks in Roche Holding Ltd. Stefanie Hennig is an employee of Cetera, Inc., and has received consulting fees from Genentech, Inc. in connection with this work. Tanja Badovinac Crnjevic and Whitney P. Kirschbrown are patent holders for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection. All authors received research support in the form of third-party writing assistance for this manuscript from Health Interactions, provided by F. Hoffmann-La Roche Ltd.
: FeDeriCa was conducted in conformance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol was reviewed and approved by the institutional review board or ethics committee at each study site.
: All patients provided written informed consent.